The Drug Topics BPA Statement
Rates of Opioid Use Disorder With Gabapentin, Benzodiazepine Coprescription Evaluated
Opioid use disorder risk was higher in a cohort of patients with chronic pain without disability.
Keeping the Focus on Community Pharmacy Advocacy at the State Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Examining Race-Based Disparities in Access to Multimodal Analgesia
Multimodal analgesia provides more effective pain management—and leads to a decrease in opioid use.
How Pharmacy Advocacy is Heating Up at the Federal Level
Drug Topics discussed independent pharmacy advocacy and PBM reform on the federal level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.
Nonopioid Suzetrigine Demonstrates Positive Phase 3 Results for Acute Pain | ASA 2024
Suzetrigine could represent the first new nonopioid drug in a distinct class of pain medications in approximately 20 years.
Pharmacy Screening Can Identify Depression in Older Adults
Normalizing conversations around mental health in older adult populations can improve outcomes.
